Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Pharmaceuticals Major
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | -1.09% | 165.32 | 0.7% | $1060.19m | |
PFE | Pfizer Inc. | 3.69% | 50.07 | 0.9% | $942.34m | |
ABBV | AbbVie, Inc. | 0.35% | 142.57 | 1.9% | $843.43m | |
MRK | Merck & Co., Inc. | 2.33% | 91.01 | 0.7% | $812.67m | |
LLY | Eli Lilly & Co. | 2.53% | 307.78 | 1.1% | $790.95m | |
BMY | Bristol-Myers Squibb Co. | 1.48% | 75.56 | 1.0% | $658.77m | |
SIGA | SIGA Technologies, Inc. | -0.16% | 24.75 | 0.0% | $468.87m | |
AZN | AstraZeneca Plc | 3.08% | 66.64 | 1.0% | $384.79m | |
GBT | Global Blood Therapeutics, Inc. | 0.27% | 66.75 | 5.6% | $307.02m | |
ALNY | Alnylam Pharmaceuticals, Inc. | 1.94% | 233.85 | 8.2% | $285.78m | |
GSK | GSK Plc | 0.84% | 36.03 | 0.3% | $273.25m | |
HZNP | Horizon Therapeutics Plc | 0.55% | 67.47 | 5.4% | $217.29m | |
KRTX | Karuna Therapeutics, Inc. | 6.17% | 277.42 | 0.0% | $207.23m | |
CCXI | ChemoCentryx, Inc. | 0.24% | 50.72 | 2.9% | $191.50m | |
NVO | Novo Nordisk A/S | -0.67% | 107.48 | 0.1% | $184.93m |
Company Profile
Royalty Pharma Plc provides drug development services. The firm operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.